The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0 increment NLS and 0 increment RING Is Lost over Time

被引:6
作者
Carr, Daniel J. J. [1 ]
Berube, Amanda [2 ]
Gershburg, Edward [3 ]
机构
[1] Univ Oklahoma, Dept Ophthalmol Microbiol & Immunol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Dept Ophthalmol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA
[3] Rational Vaccines Inc, Cambridge, MA 02139 USA
关键词
herpes simplex virus type 1; cornea; vaccine; neovascularization; visual acuity; HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; SEROPOSITIVE ASYMPTOMATIC INDIVIDUALS; NEONATAL FC-RECEPTOR; SUBUNIT VACCINE; TRANSGENIC MICE; CORNEAL NERVES; TYPE-1; EXPRESSION; IMMUNIZATION;
D O I
10.3390/pathogens10111470
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccines to viral pathogens in experimental animal models are often deemed successful if immunization enhances resistance of the host to virus challenge as measured by cumulative survival, reduction in virus replication and spread and/or lessen or eliminate overt tissue pathology. Furthermore, the duration of the protective response against challenge is another important consideration that drives a vaccination regimen. In the current study, we assessed the durability of two related vaccines, 0 increment NLS and 0 increment RING, against ocular herpes simplex virus type 1 (HSV-1) challenge in mice thirty days (short-term) and one year (long-term) following the vaccine boost. The short-term vaccine efficacy study found the 0 increment RING vaccine to be nearly equivalent to the 0 increment NLS vaccine in comparison to vehicle-vaccinated mice in terms of controlling virus replication and preserving the visual axis. By comparison, the long-term assessment of the two vaccines found notable differences and less efficacy overall as noted below. Specifically, the results show that in comparison to vehicle-vaccinated mice, the 0 increment NLS and 0 increment RING vaccinated groups were more resistant in terms of survival and virus shedding following ocular challenge. Moreover, 0 increment NLS vaccinated mice also possessed significantly less infectious virus in the peripheral and central nervous systems but not the cornea compared to mice vaccinated with vehicle or 0 increment RING which had similar levels. However, all vaccinated groups showed similar levels of blood and lymphatic vessel genesis into the central cornea 30 days post infection. Likewise, corneal opacity was also similar among all groups of vaccinated mice following infection. Functionally, the blink response and visual acuity were 25-50% lower in vaccinated mice 30 days post infection compared to measurements taken prior to infection. The results demonstrate a dichotomy between resistance to infection and functional performance of the visual axis that collectively show an overall loss in vaccine efficacy long-term in comparison to short-term studies in a conventional prime-boost protocol.
引用
收藏
页数:18
相关论文
共 60 条
[1]   Mechanisms that determine plasma cell lifespan and the duration of humoral immunity [J].
Amanna, Ian J. ;
Slifka, Mark K. .
IMMUNOLOGICAL REVIEWS, 2010, 236 :125-138
[2]   HERPES-SIMPLEX VIRUS GENOMES IN HUMAN NERVOUS-SYSTEM TISSUE ANALYZED BY POLYMERASE CHAIN-REACTION [J].
BARINGER, JR ;
PISANI, P .
ANNALS OF NEUROLOGY, 1994, 36 (06) :823-829
[3]   Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge [J].
Carr, Daniel J. J. ;
Berube, Amanda N. ;
Filiberti, Adrian ;
Gmyrek, Grzegorz B. .
VACCINE, 2021, 39 (18) :2526-2536
[4]  
Carr Daniel J J, 2020, Immunohorizons, V4, P608, DOI 10.4049/immunohorizons.2000060
[5]   Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs [J].
Cha, SC ;
Kim, YS ;
Cho, JK ;
Cho, J ;
Kim, SY ;
Kang, H ;
Cho, MH ;
Lee, HH .
VIRUS RESEARCH, 2002, 86 (1-2) :21-31
[6]   Degeneration and Regeneration of Corneal Nerves in Response to HSV-1 Infection [J].
Chucair-Elliott, Ana J. ;
Zheng, Min ;
Carr, Daniel J. J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (02) :1097-1107
[7]   Microglia and a Functional Type I IFN Pathway Are Required To Counter HSV-1-Driven Brain Lateral Ventricle Enlargement and Encephalitis [J].
Conrady, Christopher D. ;
Zheng, Min ;
van Rooijen, Nico ;
Drevets, Douglas A. ;
Royer, Derek ;
Alleman, Anthony ;
Carr, Daniel J. J. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (06) :2807-2817
[8]   VACCINIA VIRUS RECOMBINANT EXPRESSING HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-D PREVENTS LATENT HERPES IN MICE [J].
CREMER, KJ ;
MACKETT, M ;
WOHLENBERG, C ;
NOTKINS, AL ;
MOSS, B .
SCIENCE, 1985, 228 (4700) :737-740
[9]   Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease [J].
Davido, David J. ;
Tu, Eleain M. ;
Wang, Hong ;
Korom, Maria ;
Casals, Andreu Gazquez ;
Reddy, P. Jahnu ;
Mostafa, Heba H. ;
Combs, Benjamin ;
Haenchen, Steve D. ;
Morrison, Lynda A. .
JOURNAL OF VIROLOGY, 2018, 92 (17)
[10]   OCULAR INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-1 - PREVENTION OF ACUTE HERPETIC ENCEPHALITIS BY SYSTEMIC ADMINISTRATION OF VIRUS-SPECIFIC ANTIBODY [J].
DAVIS, WB ;
TAYLOR, JA ;
OAKES, JE .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :534-540